Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Congenital muscular dystrophies involving the O-mannose pathway Martin PTCurr Mol Med 2007[Jun]; 7 (4): 417-25A number of forms of congenital muscular dystrophy (CMD) have been identified that involve defects in the glycosylation of dystroglycan with O-mannosyl-linked glycans. There are at least six genes that can affect this type of glycosylation, and defects in these genes give rise to disorders that have many aspects of muscle and brain pathology in common. Overexpression of one gene implicated in CMD, LARGE, was recently shown to increase dystroglycan glycosylation and restore its function in cells taken from CMD patients. Overexpression of Galgt2, a glycosyltransferase not implicated in CMD, also alters dystroglycan glycosylation and inhibits muscular dystrophy in a mouse model of Duchenne muscular dystrophy. These findings suggest that a common approach to therapy in muscular dystrophies may be to increase the glycosylation of dystroglycan with particular glycan structures.|*Protein Modification, Translational/genetics[MESH]|Animals[MESH]|Disease Models, Animal[MESH]|Dystroglycans/genetics/*metabolism[MESH]|Galactosyltransferases/*biosynthesis/genetics[MESH]|Glycosylation[MESH]|Humans[MESH]|Mannose/genetics/*metabolism[MESH]|Mice[MESH]|Muscular Dystrophy, Duchenne/*enzymology/genetics/therapy[MESH]|N-Acetylglucosaminyltransferases/*biosynthesis/genetics[MESH] |